Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Ho Jang

Showing results (21-30 of 198) with videos related to

Pageof 20
Sort By:
Blood Research|July 5, 2013
Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendationsYoo-Jin Kim, Jun Ho Jang, Jae-Yong Kwak, et al.
Angewandte Chemie (International Ed. in English)|November 29, 2023
Paired Electrosynthesis of Formaldehyde Derivatives from CO<sub>2</sub> Reduction and Methanol OxidationJia Bin Yeo, Jun Ho Jang, Young In Jo, et al.
Annals of Pediatric Endocrinology & Metabolism|July 28, 2016
Dilated cardiomyopathy with Graves disease in a young childYu Jung Choi, Jun Ho Jang, So Hyun Park, et al.
Nanotechnology|June 23, 2017
Rise of nano effects in electrode during electrocatalytic CO<sub>2</sub> conversionKi Dong Yang, Chan Woo Lee, Jun Ho Jang, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 23, 2010
A diagnostic challenge: mild hemophilia B with normal activated partial thromboplastin timeChang-Hun Park, Ja-Young Seo, Hee-Jin Kim, et al.
Oncotarget|October 31, 2015
Iron deficient erythropoiesis might play key role in development of anemia in cancer patientsSilvia Park, Chul Won Jung, Kihyun Kim, et al.
Journal of Blood Medicine|April 22, 2026
Impact of Transfusion Dependence on Clinical and Economic Burden in Patients with Lower-Risk Myelodysplastic Syndromes: A 28-Year Retrospective StudyJun Ho Jang, Chul Won Jung, Dae-Ho Choi, et al.
Oncotarget|August 6, 2016
Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantationSilvia Park, Kihyun Kim, Jun Ho Jang, et al.
Oncotarget|May 5, 2015
Platelet response during the second cycle of decitabine treatment predicts response and survival for myelodysplastic syndrome patientsHyun Ae Jung, Chi Hoon Maeng, Moonjin Kim, et al.
International Journal of Hematology|September 2, 2015
A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromesJun Ho Jang, Hironori Harada, Hirohiko Shibayama, et al.
Pageof 20

Showing results (21-30 of 198) with videos related to

Sort By:
Pageof 20
Blood Research|July 5, 2013
Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendationsYoo-Jin Kim, Jun Ho Jang, Jae-Yong Kwak, et al.
Angewandte Chemie (International Ed. in English)|November 29, 2023
Paired Electrosynthesis of Formaldehyde Derivatives from CO<sub>2</sub> Reduction and Methanol OxidationJia Bin Yeo, Jun Ho Jang, Young In Jo, et al.
Annals of Pediatric Endocrinology & Metabolism|July 28, 2016
Dilated cardiomyopathy with Graves disease in a young childYu Jung Choi, Jun Ho Jang, So Hyun Park, et al.
Nanotechnology|June 23, 2017
Rise of nano effects in electrode during electrocatalytic CO<sub>2</sub> conversionKi Dong Yang, Chan Woo Lee, Jun Ho Jang, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 23, 2010
A diagnostic challenge: mild hemophilia B with normal activated partial thromboplastin timeChang-Hun Park, Ja-Young Seo, Hee-Jin Kim, et al.
Oncotarget|October 31, 2015
Iron deficient erythropoiesis might play key role in development of anemia in cancer patientsSilvia Park, Chul Won Jung, Kihyun Kim, et al.
Journal of Blood Medicine|April 22, 2026
Impact of Transfusion Dependence on Clinical and Economic Burden in Patients with Lower-Risk Myelodysplastic Syndromes: A 28-Year Retrospective StudyJun Ho Jang, Chul Won Jung, Dae-Ho Choi, et al.
Oncotarget|August 6, 2016
Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantationSilvia Park, Kihyun Kim, Jun Ho Jang, et al.
Oncotarget|May 5, 2015
Platelet response during the second cycle of decitabine treatment predicts response and survival for myelodysplastic syndrome patientsHyun Ae Jung, Chi Hoon Maeng, Moonjin Kim, et al.
International Journal of Hematology|September 2, 2015
A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromesJun Ho Jang, Hironori Harada, Hirohiko Shibayama, et al.
Pageof 20